Nutex Health is trading 5.07% down at $190.00, with the immediate catalyst unclear.
- No clear company-specific announcement explaining the November 2 decline surfaced in available coverage.
- Third-quarter results are scheduled for November 5 and have not yet been reported.
- Major indexes were higher; no trading-volume figure was provided in the supplied price context.